{"schema_version":"secwatch.filing_event.v1","accession":"0001299130-26-000092","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2026-06-04T21:19:08+00:00","discovered_at":"2026-06-04T21:20:00.257909+00:00","generated_at":"2026-06-04T21:21:37.582702+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Shareholders approve 16M share increase in equity plan at Pacific Biosciences annual meeting","bullets":["Stockholders approved amendment to 2020 Equity Incentive Plan, adding 16,000,000 shares for future grants.","Four Class III directors elected: Ericson, Ordoñez, Smith, Gibson, Henry, Milligan.","Ernst & Young ratified as independent registered public accounting firm for FY2026.","Advisory say-on-pay proposal approved with 114,050,930 votes for, 21,239,989 against.","Annual meeting had ~65% of shares represented (203,009,375 of 310,487,099 outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0001299130-26-000092","json":"https://secwatch.observer/filing/0001299130-26-000092.json","markdown":"https://secwatch.observer/filing/0001299130-26-000092.md","text":"https://secwatch.observer/filing/0001299130-26-000092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/pacb-20260603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T21:21:37.582702+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a204815f84109961cefa5faccfb77c6a3301a26","claim":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Election of Four Class III Directors at the 2026-06-03 meeting.","evidence_excerpt":"Proposal 1: Election of Four Class III Directors Name of Director For Against Abstain Broker Non-Votes William Ericson 128,010,323 8,109,601 1,111,140 65,778,311 Kathy Ordoñez 130,522,400 5,673,816 1,034,848 65,778,311 Christopher M. Smith 131,731,235 4,069,337 1,430,492 65,778,311 Chris Gibson, Ph.D. 131,899,750 4,107,270 1,224,044 65,778,311 Christian O. Henry 129,999,918 5,924,115 1,307,031 65,778,311 John F. Milligan, Ph.D. 130,471,635 5,650,906 1,108,523 65,778,311 Each director nominee was duly elected","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-03"}],"fact_type":"shareholder_vote"},{"claim_id":"4d8c66b0b9c9e7edcc17c32aa60917617d67fb29","claim":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-03 meeting.","evidence_excerpt":"Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 198,046,666 3,990,483 972,226 — The stockholders ratified the appointment of Ernst & Young LLP","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-03"}],"fact_type":"shareholder_vote"},{"claim_id":"b8772152e7e0f9c57469b1465b31299f13ce59f1","claim":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Advisory Vote on Approval of Named Executive Officer Compensation at the 2026-06-03 meeting.","evidence_excerpt":"Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation For Against Abstain Broker Non-Votes 114,050,930 21,239,989 1,940,145 65,778,311 The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-03"}],"fact_type":"shareholder_vote"},{"claim_id":"c2e13a5d771550210e6c7263b1f2747b9a004431","claim":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Approval of Amendment to the 2020 Equity Incentive Plan at the 2026-06-03 meeting.","evidence_excerpt":"Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan For Against Abstain Broker Non-Votes 114,865,820 20,469,132 1,896,112 65,778,311 The stockholders approved the amendment to the 2020 Plan","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-03"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}